Drug
Certoparin clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses certoparin is read from its arms, and is right about nine times in ten.
Testing it · 4
- Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical PatientsCompletedPhase 3Novartis PharmaceuticalsNCT00311753Written as Certoparin
- Atrial Fibrillation Feasibility Certoparin Trial - AFFECTCompletedPhase 3NovartisNCT00171769Written as Certoparin
- A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical PatientsCompletedPhase 3NovartisNCT00451412Written as Certoparin
- Certoparin in Renal Patients Undergoing HemodialysisCompletedPhase 3NovartisNCT01179620Written as Certoparin
Codes
What other systems call certoparin · ClinicalTrials.gg INT004208
- MeSH (NLM) C403769certoparinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) V72OT3K19ICERTOPARINOne source NLM
- RxNorm 152610One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C403769 | certoparin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | V72OT3K19I | CERTOPARIN | One source NLM |
| RxNorm | 152610 | — | One source FDA |
Also registered as certoparin sodium (UNII N816FF9P2W · RxNorm 152612).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.